08048035996
Krabeva 100mg Good Quality Injection to UK - London | Phoenix Exim | Trusted Exporter

1. General Information

Krabeva 100 mg Injection is an oncology medicine containing bevacizumab, a biologic monoclonal antibody. It belongs to the class of medicines known as anti-neoplastic/anti-angiogenic agents. The medicine is administered as an intravenous infusion under the supervision of an appropriately qualified healthcare professional.

Bevacizumab works by targeting vascular endothelial growth factor (VEGF), a protein involved in the formation of new blood vessels. By inhibiting VEGF activity, bevacizumab can interfere with the blood-vessel formation that supports tumour growth.

Important: Krabeva is a prescription oncology medicine and should be used only according to the treating oncologist's prescription and the approved indication applicable in the patient's country.

2. Product Information

  • Brand: Krabeva
  • Active ingredient: Bevacizumab
  • Strength: 100 mg/4 mL
  • Concentration: 25 mg/mL
  • Dosage form: Concentrate for solution for intravenous infusion
  • Route: Intravenous (IV) infusion
  • Therapeutic class: Anti-neoplastic / anti-angiogenic agent
  • Vial: Single-use vial
  • Manufacturer: Biocon/ Biocon Biologics, depending on the market and product presentation
  • Storage: Refrigerated at 2–8°C according to product information; protect the product from inappropriate storage and handling.

The official product documentation confirms that Krabeva is available in both 100 mg/4 mL and 400 mg/16 mL presentations.

3. Uses of Krabeva 100 mg Injection

Bevacizumab-containing products such as Krabeva are used, in combination with other anticancer treatments where appropriate, for several types of cancer. Approved indications can vary according to the regulatory authority and product label.

The Krabeva product information includes uses in conditions such as:

  • Metastatic colorectal cancer
  • Metastatic breast cancer in specified treatment settings
  • Advanced, metastatic or recurrent non-squamous non-small-cell lung cancer
  • Advanced or metastatic renal cell cancer
  • Certain cervical cancers
  • Certain ovarian, fallopian-tube and primary peritoneal cancers
  • Other oncology indications where specifically approved by the relevant regulatory authority.

The exact treatment combination, dose and indication depend on the cancer type, previous treatment, patient characteristics and applicable local prescribing information.

4. Benefits of This Medicine

Potential therapeutic benefits of bevacizumab-based treatment include:

  • Helps inhibit VEGF-mediated formation of new blood vessels.
  • Can reduce the tumour's ability to develop and maintain its blood supply.
  • May help slow tumour progression when used in appropriate cancer treatment regimens.
  • Can be combined with chemotherapy or other approved cancer treatments for selected indications.
  • Provides a targeted biological treatment approach rather than acting as a conventional cytotoxic chemotherapy drug alone.

Note: Benefits vary between cancer types and individual patients. Krabeva should not be described as a guaranteed cure or as suitable for every cancer patient.

5. Side Effects of Krabeva 100 mg Injection

Bevacizumab can cause side effects ranging from mild to serious. Important adverse reactions described in product information include:

  • High blood pressure
  • Protein in the urine
  • Bleeding or haemorrhage
  • Delayed wound healing
  • Blood clots or arterial/venous thromboembolic events
  • Gastrointestinal perforation
  • Fistula formation
  • Infusion-related reactions
  • Kidney-related complications
  • Rare neurological complications such as posterior reversible encephalopathy syndrome
  • Severe or potentially life-threatening complications in some patients.

Patients should promptly report unusual bleeding, severe abdominal pain, chest pain, breathing difficulty, severe headache, neurological symptoms, or other serious or unexpected symptoms to their healthcare professional.

6. Common Side Effects

Depending on the treatment regimen and patient population, reported side effects may include:

  • Weakness or fatigue
  • Nausea
  • Vomiting
  • Diarrhoea
  • Abdominal discomfort or pain
  • Headache
  • High blood pressure
  • Loss of appetite
  • Nosebleeds
  • Proteinuria
  • Joint or muscle discomfort

Side-effect frequency can differ depending on the accompanying chemotherapy and the underlying disease.

7. How to Use Krabeva 100 mg Injection

Krabeva is not a self-administered injection.

It should be:

  1. Prescribed by an appropriately qualified physician, usually an oncologist.
  2. Prepared and diluted according to the approved product information.
  3. Administered through intravenous infusion by qualified healthcare personnel.
  4. Given according to the prescribed dose and treatment schedule.
  5. Monitored during treatment for infusion reactions and other clinically important adverse effects.

The dose is generally determined according to the cancer indication, body weight, treatment regimen and clinical condition. The 100 mg vial is not automatically one complete treatment dose.

Patients should never change the dose, infusion interval or treatment duration without their oncologist's instructions.

8. How This Medicine Works

Krabeva contains bevacizumab, a humanised monoclonal antibody that targets vascular endothelial growth factor (VEGF).

VEGF plays an important role in angiogenesis—the formation of new blood vessels. Tumours can use newly formed blood vessels to obtain oxygen and nutrients needed for growth.

Bevacizumab binds to VEGF and inhibits its biological activity. This can reduce the formation of new blood vessels and thereby interfere with the vascular support of tumours.

This mechanism is commonly described as anti-angiogenic therapy.

9. Safety Advice for Krabeva 100 mg Injection

  • Use only under specialist medical supervision.
  • Tell the doctor about previous allergic reactions to bevacizumab or other biologic medicines.
  • Blood pressure should be monitored during treatment.
  • Urine may need to be monitored for protein.
  • Inform the healthcare team about planned surgery because bevacizumab can affect wound healing.
  • Tell the doctor about any history of bleeding, blood clots, gastrointestinal problems, hypertension or other significant medical conditions.
  • Inform the doctor about all medicines and cancer treatments being received.
  • Pregnancy should be discussed with the treating physician because bevacizumab can cause fetal harm.
  • Appropriate contraception may be required during treatment and for the period specified in the approved product information.
  • Do not use the product for intravitreal administration unless a specifically approved formulation and indication exists; the Krabeva product information states that it is not formulated for intravitreal use.
  • Maintain the required cold-chain storage conditions.
  • Do not use a vial that is damaged, improperly stored, expired or otherwise unsuitable.
  • This medicine should be supplied and used according to the prescription and regulatory requirements of the destination country.

10. Frequently Asked Questions (FAQs)

Q1. What is Krabeva 100 mg Injection?

Krabeva 100 mg is a bevacizumab concentrate for intravenous infusion containing 100 mg of bevacizumab in 4 mL.

Q2. What is the active ingredient in Krabeva?

The active ingredient is bevacizumab.

Q3. What is Krabeva used for?

It is used as part of treatment regimens for certain cancers, including selected colorectal, breast, lung, renal, cervical and gynecological cancers, depending on the approved indication.

Q4. Is Krabeva a chemotherapy medicine?

It is an anti-angiogenic monoclonal antibody rather than a conventional cytotoxic chemotherapy drug. It may, however, be administered together with chemotherapy.

Q5. How is Krabeva administered?

It is administered by intravenous infusion by qualified healthcare personnel.

Q6. Can I inject Krabeva myself?

No. Krabeva should be prepared and administered by appropriately trained healthcare professionals.

Q7. What is the strength of Krabeva 100 mg?

The 100 mg presentation contains 100 mg bevacizumab in 4 mL, equivalent to 25 mg/mL.

Q8. Does Krabeva have a 400 mg presentation?

Yes. Product information lists a 400 mg/16 mL presentation in addition to the 100 mg/4 mL presentation.

Q9. Does Krabeva cure cancer?

It should not be described as a guaranteed cure. Its purpose is to help control particular cancers when used in an appropriate treatment regimen.

Q10. How should Krabeva be stored?

The product should generally be stored under refrigerated conditions of 2–8°C, following the approved product label and cold-chain requirements.

Q11. Can Krabeva be used during pregnancy?

Bevacizumab may cause fetal harm. Pregnancy, planned pregnancy and contraception should be discussed with the treating physician before treatment.

Q12. Is Krabeva available in different strengths?

Yes. The documented presentations include 100 mg/4 mL and 400 mg/16 mL.

Q13. Is Krabeva the same as bevacizumab?

Krabeva is a brand containing the active ingredient bevacizumab. It is a biologic/biosimilar product, and substitution should follow the applicable regulatory and medical requirements.

11. Substitute for Krabeva 100 mg Injection

Because Krabeva contains bevacizumab, other approved bevacizumab products may be considered as alternatives in appropriate circumstances. Examples of bevacizumab brands available in various markets include:

  • Avastin
  • Bevatas
  • Bevacirel
  • Bryxta
  • Other locally approved bevacizumab products

The availability and regulatory status of these products differ by country. A substitute should not be selected solely on brand name or strength. The treating oncologist or pharmacist should confirm the active ingredient, concentration, indication, dosage regimen, formulation and regulatory status before substitution.

12. SEO Keywords for Phoenix Exim

Primary Keywords

  1. Krabeva 100mg Injection exporter from India
  2. Krabeva 100mg Injection supplier India
  3. Krabeva 100mg Injection wholesaler India
  4. Krabeva 100mg Injection pharmaceutical exporter
  5. Krabeva 100mg Injection supplier from Nagpur
  6. Bevacizumab 100mg/4ml Injection exporter India
  7. Bevacizumab 100mg Injection supplier India
  8. Krabeva Bevacizumab 100mg Injection exporter
  9. Krabeva 100mg oncology medicine exporter
  10. Krabeva 100mg cancer medicine supplier India

Long-Tail B2B Keywords

  1. Buy Krabeva 100mg Injection from pharmaceutical exporter in India
  2. Krabeva 100mg Bevacizumab Injection wholesale supplier from India
  3. Krabeva 100mg Injection international pharmaceutical supplier
  4. Krabeva 100mg Injection B2B pharmaceutical supplier India
  5. Krabeva Bevacizumab Injection bulk pharmaceutical exporter
  6. Bevacizumab 100mg/4ml oncology injection exporter from Nagpur India
  7. Krabeva 100mg Injection supplier for international pharmaceutical buyers
  8. Krabeva 100mg Injection pharmaceutical export company India
  9. Krabeva 100mg Injection distributor and exporter from India
  10. Krabeva 100mg Bevacizumab oncology product supplier India

Country-Focused Keywords

  1. Krabeva 100mg Injection exporter to USA
  2. Krabeva 100mg Injection supplier to UK
  3. Krabeva 100mg Injection exporter to Australia
  4. Krabeva 100mg Injection supplier to Singapore
  5. Krabeva 100mg Injection exporter to Canada
  6. Krabeva 100mg Injection supplier to South Korea
  7. Krabeva 100mg Injection exporter to UAE
  8. Bevacizumab 100mg Injection exporter from India to USA UK Australia
  9. Krabeva 100mg oncology medicine exporter from Nagpur India
  10. Bevacizumab Injection international supplier from India to global markets

Phoenix Exim SEO Keywords

  1. Phoenix Exim Krabeva 100mg Injection supplier
  2. Phoenix Exim Bevacizumab Injection exporter India
  3. Phoenix Exim oncology medicine exporter from Nagpur
  4. Phoenix Exim Krabeva 100mg pharmaceutical supplier
  5. Phoenix Exim Bevacizumab 100mg international medicine exporter
  6. Trusted pharmaceutical exporter from Nagpur India
  7. Indian oncology medicine exporter for international buyers
  8. Pharmaceutical medicine exporter from Nagpur India
  9. Bevacizumab oncology product supplier from India
  10. Krabeva 100mg pharmaceutical export supplier Phoenix Exim

Aug 13th, 2026 1:52 PM

Keywords